H Grant Skaggs Jr
Examiner (ID: 16447)
Most Active Art Unit | 3101 |
Art Unit(s) | 3651, 1301, 3615, 3653, 2899, 3101 |
Total Applications | 2062 |
Issued Applications | 1836 |
Pending Applications | 39 |
Abandoned Applications | 187 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 5873940
[patent_doc_number] => 20060166192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Detection of protease-resistant prion protein following a spontaneous transformation reaction'
[patent_app_type] => utility
[patent_app_number] => 11/305616
[patent_app_country] => US
[patent_app_date] => 2005-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3747
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166192.pdf
[firstpage_image] =>[orig_patent_app_number] => 11305616
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/305616 | Detection of protease-resistant prion protein following a spontaneous transformation reaction | Dec 15, 2005 | Abandoned |
Array
(
[id] => 5976693
[patent_doc_number] => 20110070575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'Immunomodulatory Compositions, Combinations and Methods'
[patent_app_type] => utility
[patent_app_number] => 11/720862
[patent_app_country] => US
[patent_app_date] => 2005-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7900
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0070/20110070575.pdf
[firstpage_image] =>[orig_patent_app_number] => 11720862
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/720862 | Immunomodulatory Compositions, Combinations and Methods | Dec 7, 2005 | Abandoned |
Array
(
[id] => 83167
[patent_doc_number] => 07741054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'High throughput prion assays'
[patent_app_type] => utility
[patent_app_number] => 11/273487
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 21886
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/741/07741054.pdf
[firstpage_image] =>[orig_patent_app_number] => 11273487
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/273487 | High throughput prion assays | Nov 13, 2005 | Issued |
Array
(
[id] => 4903924
[patent_doc_number] => 20080113337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Method of Examining/Judging Presence of Virus Infection such as HIV or Presence of Prion Infection by Near-Infrared Spectroscopy and Device Used in Same'
[patent_app_type] => utility
[patent_app_number] => 11/718980
[patent_app_country] => US
[patent_app_date] => 2005-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12882
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113337.pdf
[firstpage_image] =>[orig_patent_app_number] => 11718980
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/718980 | Method of Examining/Judging Presence of Virus Infection such as HIV or Presence of Prion Infection by Near-Infrared Spectroscopy and Device Used in Same | Nov 9, 2005 | Abandoned |
Array
(
[id] => 586116
[patent_doc_number] => 07439042
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-21
[patent_title] => 'Yeast-based therapeutic for chronic hepatitis C infection'
[patent_app_type] => utility
[patent_app_number] => 11/254252
[patent_app_country] => US
[patent_app_date] => 2005-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 50
[patent_no_of_words] => 31998
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/439/07439042.pdf
[firstpage_image] =>[orig_patent_app_number] => 11254252
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/254252 | Yeast-based therapeutic for chronic hepatitis C infection | Oct 17, 2005 | Issued |
Array
(
[id] => 5874325
[patent_doc_number] => 20060166320
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'In vitro expression of the HCV ARFP/F-core‘coding open reading frame'
[patent_app_type] => utility
[patent_app_number] => 11/240595
[patent_app_country] => US
[patent_app_date] => 2005-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 13680
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166320.pdf
[firstpage_image] =>[orig_patent_app_number] => 11240595
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/240595 | In vitro expression of the HCV ARFP/F-core‘coding open reading frame | Oct 2, 2005 | Abandoned |
Array
(
[id] => 4932848
[patent_doc_number] => 20080003623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-03
[patent_title] => 'Monitoring Agent for Seriousness of Hepatitis'
[patent_app_type] => utility
[patent_app_number] => 11/575109
[patent_app_country] => US
[patent_app_date] => 2005-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9918
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20080003623.pdf
[firstpage_image] =>[orig_patent_app_number] => 11575109
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/575109 | Monitoring Agent for Seriousness of Hepatitis | Oct 2, 2005 | Abandoned |
Array
(
[id] => 5322885
[patent_doc_number] => 20090060875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'HCV Vaccines for Chronic HCV Patients'
[patent_app_type] => utility
[patent_app_number] => 11/577798
[patent_app_country] => US
[patent_app_date] => 2005-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4585
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0060/20090060875.pdf
[firstpage_image] =>[orig_patent_app_number] => 11577798
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/577798 | HCV Vaccines for Chronic HCV Patients | Sep 22, 2005 | Abandoned |
Array
(
[id] => 5178043
[patent_doc_number] => 20070179103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Immunostimulatory oligonucleotide multimers'
[patent_app_type] => utility
[patent_app_number] => 11/234396
[patent_app_country] => US
[patent_app_date] => 2005-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24683
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0179/20070179103.pdf
[firstpage_image] =>[orig_patent_app_number] => 11234396
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/234396 | Immunostimulatory oligonucleotide multimers | Sep 21, 2005 | Issued |
Array
(
[id] => 5808325
[patent_doc_number] => 20060094680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Immunostimulatory oligonucleotide multimers'
[patent_app_type] => utility
[patent_app_number] => 11/234074
[patent_app_country] => US
[patent_app_date] => 2005-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 24378
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094680.pdf
[firstpage_image] =>[orig_patent_app_number] => 11234074
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/234074 | Immunostimulatory oligonucleotide multimers | Sep 21, 2005 | Issued |
Array
(
[id] => 5794251
[patent_doc_number] => 20060014932
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Purified and isolated protein zero related (PZR) and therapeutic and screening methods using same'
[patent_app_type] => utility
[patent_app_number] => 11/219146
[patent_app_country] => US
[patent_app_date] => 2005-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 35163
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014932.pdf
[firstpage_image] =>[orig_patent_app_number] => 11219146
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/219146 | Purified and isolated protein zero related (PZR) and therapeutic and screening methods using same | Sep 1, 2005 | Abandoned |
Array
(
[id] => 5710024
[patent_doc_number] => 20060051369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'ADAR1 antiviral pathway'
[patent_app_type] => utility
[patent_app_number] => 11/212258
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13717
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051369.pdf
[firstpage_image] =>[orig_patent_app_number] => 11212258
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/212258 | ADAR1 antiviral pathway | Aug 25, 2005 | Abandoned |
Array
(
[id] => 5747474
[patent_doc_number] => 20060110405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Plasma or serum fraction for treatment and prevention of viral infections and related conditions'
[patent_app_type] => utility
[patent_app_number] => 11/209571
[patent_app_country] => US
[patent_app_date] => 2005-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 31219
[patent_no_of_claims] => 117
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20060110405.pdf
[firstpage_image] =>[orig_patent_app_number] => 11209571
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/209571 | Plasma or serum fraction for treatment and prevention of viral infections and related conditions | Aug 21, 2005 | Abandoned |
Array
(
[id] => 4954913
[patent_doc_number] => 20080187937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'Method For Measuring Dynamics Of Self-Assembling Systems Of Biological Molecules In Vivo And Uses For Discovering Or Evaluating Therapeutic Agents'
[patent_app_type] => utility
[patent_app_number] => 11/573374
[patent_app_country] => US
[patent_app_date] => 2005-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 24399
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20080187937.pdf
[firstpage_image] =>[orig_patent_app_number] => 11573374
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/573374 | Method For Measuring Dynamics Of Self-Assembling Systems Of Biological Molecules In Vivo And Uses For Discovering Or Evaluating Therapeutic Agents | Aug 7, 2005 | Abandoned |
Array
(
[id] => 5895423
[patent_doc_number] => 20060003962
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Methods and products related to treatment and prevention of hepatitis C virus infection'
[patent_app_type] => utility
[patent_app_number] => 11/183253
[patent_app_country] => US
[patent_app_date] => 2005-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 25853
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003962.pdf
[firstpage_image] =>[orig_patent_app_number] => 11183253
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/183253 | Methods and products related to treatment and prevention of hepatitis C virus infection | Jul 14, 2005 | Abandoned |
Array
(
[id] => 5821052
[patent_doc_number] => 20060025365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Immunostimulatory oligonucleotide multimers'
[patent_app_type] => utility
[patent_app_number] => 11/174448
[patent_app_country] => US
[patent_app_date] => 2005-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24713
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20060025365.pdf
[firstpage_image] =>[orig_patent_app_number] => 11174448
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/174448 | Immunostimulatory oligonucleotide multimers | Jun 30, 2005 | Issued |
Array
(
[id] => 4778277
[patent_doc_number] => 20080286275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Antigen Binding Proteins Directed Against Scavenger Receptor B1 that Inhibit Hcv Replication'
[patent_app_type] => utility
[patent_app_number] => 11/631765
[patent_app_country] => US
[patent_app_date] => 2005-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6717
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286275.pdf
[firstpage_image] =>[orig_patent_app_number] => 11631765
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/631765 | Antigen binding proteins directed against scavenger receptor B1 that inhibit HCV replication | Jun 30, 2005 | Issued |
Array
(
[id] => 5794032
[patent_doc_number] => 20060014713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-19
[patent_title] => 'Immunostimulatory oligonucleotide multimers'
[patent_app_type] => utility
[patent_app_number] => 11/153054
[patent_app_country] => US
[patent_app_date] => 2005-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24465
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20060014713.pdf
[firstpage_image] =>[orig_patent_app_number] => 11153054
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/153054 | Immunostimulatory oligonucleotide multimers | Jun 14, 2005 | Abandoned |
Array
(
[id] => 132312
[patent_doc_number] => 07695918
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-04-13
[patent_title] => 'Process for detecting PrPSC using an antibiotic from the family of aminoglycosides'
[patent_app_type] => utility
[patent_app_number] => 11/151066
[patent_app_country] => US
[patent_app_date] => 2005-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 13
[patent_no_of_words] => 4107
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/695/07695918.pdf
[firstpage_image] =>[orig_patent_app_number] => 11151066
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/151066 | Process for detecting PrPSC using an antibiotic from the family of aminoglycosides | Jun 12, 2005 | Issued |
Array
(
[id] => 4893426
[patent_doc_number] => 20080102524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'Freeze-Dried Composition of Inactivated Virus Envelope with Membrane Fusion Activity'
[patent_app_type] => utility
[patent_app_number] => 11/629289
[patent_app_country] => US
[patent_app_date] => 2005-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6685
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20080102524.pdf
[firstpage_image] =>[orig_patent_app_number] => 11629289
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629289 | Freeze-Dried Composition of Inactivated Virus Envelope with Membrane Fusion Activity | Jun 9, 2005 | Abandoned |